Indicator summary: Leaning bullish (3 bullish, 2 bearish, 0 neutral). As of 2026-11-05, the close was $160.15: 15.1% above the 50-day average and 14.3% above the 200-day average, which is rising. RSI (14) is 82, overbought. MACD is bullish. The stock sits 93% of the way up its 52-week range of $120.02 to $163.13, on 1.2x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $139.17 | Price 15.1% above |
| 200-day average | $140.16 | Price 14.3% above, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 82 | Overbought |
| MACD (12, 26, 9) | +5.74 vs +3.67 | Line above signal |
| 52-week range | $120.02 to $163.13 | 93% of the way up the range |
| Volume vs 20-day average | 1.2x | Normal |
Base rates use EXR's own daily history since 2004; they describe the past, not a forecast.
As of 2026-11-05, EXR's 14-day RSI is 82, which is overbought (above 70). When it had RSI above 70 (434 days), it was higher 63 trading days later 66% of the time, median +4.6%.
Yes. EXR closed at $160.15 on 2026-11-05, 14.3% above its 200-day average of $140.16, which is rising. When it closed above its 200-day average (3,846 days), it was higher 63 trading days later 72% of the time, median +6.4%.
Yes. EXR closed at $160.15 on 2026-11-05, 15.1% above its 50-day average of $139.17. When it closed above its 50-day average (3,502 days), it was higher 63 trading days later 69% of the time, median +5.5%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is +5.74 against a signal line of +3.67, so MACD is bullish.
Yes. At $160.15 it sits 93% of the way up its 52-week range of $120.02 to $163.13, 1.8% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 2 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
EXR analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.